BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05 FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
BRIEF published on 08/19/2024 at 13:05, 1 year 8 months ago Tanvex BioPharma USA, Inc. franchit deux étapes réglementaires aux États-Unis : la FDA approuve Nypozi(TM) et la FDA accepte la demande de licence de produits biologiques biosimilaires pour le TX-05 Traitement Du Cancer Approbation De La FDA Biosimilaire Innovation Dans Le Domaine De La Santé Neutropénie
BRIEF published on 08/19/2024 at 12:50, 1 year 8 months ago Northern Dynasty: Alaska Court Grants Motion to Add USACE to Existing EPA Complaint Pebble Project Northern Dynasty Alaska Court EPA Complaint USACE Inclusion
BRIEF published on 08/19/2024 at 12:50, 1 year 8 months ago Northern Dynasty : Un tribunal de l'Alaska accorde une motion visant à ajouter l'USACE à la plainte existante de l'EPA Dynastie Du Nord Tribunal De L'Alaska Plainte Auprès De L'EPA Inclusion De L'USACE Projet Pebble
BRIEF published on 08/19/2024 at 12:40, 1 year 8 months ago Epique Realty Announces Strategic Expansion Into New Mexico and Utah Expansion Real Estate Innovative Approach William Lambert New Markets
BRIEF published on 08/19/2024 at 12:40, 1 year 8 months ago Epique Realty annonce une expansion stratégique au Nouveau-Mexique et dans l'Utah Expansion Immobilier William Lambert Nouveaux Marchés Approche Innovante
BRIEF published on 08/19/2024 at 12:35, 1 year 8 months ago Bénéteau : Transactions sur actions propres du 12 au 16 août 2024 Euronext Paris BENETEAU Transactions D'actions Marché Prix Pondéré
BRIEF published on 08/19/2024 at 12:35, 1 year 8 months ago Bénéteau: Transactions on own shares from August 12 to 16, 2024 Euronext Paris BENETEAU Stock Transactions Walk Weighted Price
BRIEF published on 08/19/2024 at 12:35, 1 year 8 months ago NanoViricides Advances Towards Phase II Trial of NV-387 NanoViricides NV-387 Antiviral Therapy Phase II Trial RSV, COVID, Influenza
BRIEF published on 08/19/2024 at 12:35, 1 year 8 months ago NanoViricides avance vers la phase II de l'essai du NV-387 NanoViricides NV-387 Essai De Phase II Thérapie Antivirale VRS, COVID, Grippe
Published on 05/07/2026 at 14:00, 2 minutes ago Adcore to Publish First Quarter 2026 Results on May 14, 2026
Published on 05/07/2026 at 13:30, 32 minutes ago UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas
Published on 05/07/2026 at 13:00, 1 hour 2 minutes ago Eagle Plains Expands George Lake Deposit Mineralization, Reports 3.48% Zn+Pb over 45.1m in Step-out Drilling
Published on 05/07/2026 at 13:00, 1 hour 2 minutes ago Gamma Resources Appoints Connor Messler as President
Published on 05/07/2026 at 13:50, 12 minutes ago Advaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure
Published on 05/07/2026 at 13:35, 27 minutes ago Now Is Your Spark: Huawei Empowers Everyone to Be the Star of Their Own Life with All-Scenario Technologies
Published on 05/07/2026 at 13:33, 28 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 05/07/2026 at 13:05, 57 minutes ago Semidynamics and SiPearl Announce Strategic Cooperation to Develop EU-Sovereign Rack-Scale AI Compute Platform
Published on 05/07/2026 at 07:43, 6 hours 19 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 20 hours 2 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 20 hours 2 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 20 hours 2 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
